POPULATION PHARMACOKINETICS OF TOBRAMYCIN

被引:51
作者
AARONS, L [1 ]
VOZEH, S [1 ]
WENK, M [1 ]
WEISS, P [1 ]
FOLLATH, F [1 ]
机构
[1] UNIV BASEL,DEPT MED,DIV CLIN PHARMACOL,CH-4051 BASEL,SWITZERLAND
关键词
D O I
10.1111/j.1365-2125.1989.tb05431.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:305 / 314
页数:10
相关论文
共 24 条
[21]   CONTROLLED INVESTIGATION OF PHARMACOKINETICS OF GENTAMICIN AND TOBRAMYCIN IN OBESE SUBJECTS [J].
SCHWARTZ, SN ;
PAZIN, GJ ;
LYON, JA ;
HO, M ;
PASCULLE, AW .
JOURNAL OF INFECTIOUS DISEASES, 1978, 138 (04) :499-505
[22]  
SMITH CR, 1986, CLIN PHARMACOL THER, V39, P229
[23]   CHANGES IN THE APPARENT HALF-LIFE OF GENTAMICIN AND TOBRAMYCIN WITHOUT DETECTABLE CHANGES IN CREATININE CLEARANCE [J].
VOZEH, S ;
SPRING, P ;
WENK, M ;
FOLLATH, F .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (06) :629-631
[24]   SERUM LEVEL MONITORING OF ANTIBACTERIAL DRUGS - A REVIEW [J].
WENK, M ;
VOZEH, S ;
FOLLATH, F .
CLINICAL PHARMACOKINETICS, 1984, 9 (06) :475-492